2005
DOI: 10.1016/j.intimp.2005.02.012
|View full text |Cite
|
Sign up to set email alerts
|

Effects of the kinase inhibitor CGP41251 (PKC 412) on lymphocyte activation and TNF-α production

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
4
0

Year Published

2005
2005
2015
2015

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 10 publications
(4 citation statements)
references
References 44 publications
(50 reference statements)
0
4
0
Order By: Relevance
“…The N-benzoylated staurosporine analogue, midostaurin, was originally identified as a PKC inhibitor but has subsequently been found to inhibit both tyrosine kinase and serine/threonine kinases (57). Midostaurin is a potent radiation sensitizer both in cell culture and human tumor xenograft studies through a phosphoinositide-3-kinase/Akt pathway (58).…”
Section: Pkc Inhibitorsmentioning
confidence: 99%
“…The N-benzoylated staurosporine analogue, midostaurin, was originally identified as a PKC inhibitor but has subsequently been found to inhibit both tyrosine kinase and serine/threonine kinases (57). Midostaurin is a potent radiation sensitizer both in cell culture and human tumor xenograft studies through a phosphoinositide-3-kinase/Akt pathway (58).…”
Section: Pkc Inhibitorsmentioning
confidence: 99%
“…Our laboratory has previously developed pharmacodynamic (PD) assays incorporating flow cytometric analyses that focus on end products of specific intracellular biochemical cascades in lymphocytes, including cell-surface markers of lymphocyte activation, cytokine production by T-cells and lymphocyte proliferation. The relevancy of these assays in the estimation of the resulting effects of candidate immunosuppressive drugs has been established in small (17)(18)(19) and large (20 -22) animal models and was recently verified in human blood (20,(23)(24)(25) and in stable human recipients of kidney allografts (26).…”
mentioning
confidence: 99%
“…NF-κB, as a transcription factor, exists on TNF-α signal transduction pathway and cAMP/PKA signaling pathway in lymphocytes. And inhibiting NF-κB expressions can decrease TNF-α content [32][33][34][35]. Our previous research revealed that TNF-α contents decreased in AlCl 3 -treated lymphocytes of rats [21].…”
Section: Discussionmentioning
confidence: 93%